About HYCOR BioMedical
HYCOR BioMedical is a company based in Garden Grove (United States) founded in 1981.. HYCOR BioMedical has raised $99.57 million across 5 funding rounds. HYCOR BioMedical offers products and services including NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit. HYCOR BioMedical operates in a competitive market with competitors including Exagen, Kypha, TBG Diagnostics, Lophius Biosciences and SmartHealth, among others.
- Headquarter Garden Grove, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hycor Biomedical Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$99.57 M (USD)
in 5 rounds
-
Latest Funding Round
$20 M (USD), Series D
Dec 29, 2020
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HYCOR BioMedical
HYCOR BioMedical offers a comprehensive portfolio of products and services, including NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Instrument for allergy blood testing and laboratory efficiency.
Kits for detecting specific IgE allergens in diagnostics.
Kit for multiple real-time PCR applications in molecular diagnostics.
Unlock access to complete
Funding Insights of HYCOR BioMedical
HYCOR BioMedical has successfully raised a total of $99.57M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $20.0M
-
First Round
First Round
(01 Aug 2017)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series D - HYCOR BioMedical | Valuation |
investors |
|
| Sep, 2020 | Amount | Series C - HYCOR BioMedical | Valuation |
investors |
|
| Jan, 2020 | Amount | Series C - HYCOR BioMedical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by HYCOR BioMedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HYCOR BioMedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hycor Biomedical Comparisons
Competitors of HYCOR BioMedical
HYCOR BioMedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exagen, Kypha, TBG Diagnostics, Lophius Biosciences and SmartHealth, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics kits, instruments, and software are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostics for vascular, metabolic, and oncological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hycor Biomedical
Frequently Asked Questions about HYCOR BioMedical
When was HYCOR BioMedical founded?
HYCOR BioMedical was founded in 1981 and raised its 1st funding round 36 years after it was founded.
Where is HYCOR BioMedical located?
HYCOR BioMedical is headquartered in Garden Grove, United States. It is registered at Garden Grove, California, United States.
Is HYCOR BioMedical a funded company?
HYCOR BioMedical is a funded company, having raised a total of $99.57M across 5 funding rounds to date. The company's 1st funding round was a Series C of $15M, raised on Aug 01, 2017.
What does HYCOR BioMedical do?
HYCOR BioMedical was founded in 1981 and is located in Garden Grove, United States. In vitro diagnostic instruments and reagents are developed for autoimmune diseases and allergies. Flagship products include the HYTEC 288 Plus, which is used for allergy and autoimmune antibody testing, and the HYCOR Ultra-Sensitive System, which is applied in ELISA procedures. Operations center on clinical diagnostic tools within the biomedical sector.
Who are the top competitors of HYCOR BioMedical?
HYCOR BioMedical's top competitors include Exagen, SmartHealth and Lophius Biosciences.
What products or services does HYCOR BioMedical offer?
HYCOR BioMedical offers NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit.